Autoimmune Disease Treatment Market Overview
Market Research Future
(MRFR)’s latest assessment reveals that the global autoimmune disease treatment market size is expected to thrive at Steady
CAGR during the forecast period. The market signifies massive unmet needs for
diagnosis. It is projected to favor the expansion of the global market by
bringing advanced, precise and effective drugs and treatments.
Definite causes for the
development of autoimmune diseases have not been identified. Thus,
the emphasis is on the early diagnosis of the disease. Increasing
awareness coupled with large-scale prevalence is likely to aid the
proliferation of the Autoimmune
Disease Treatment Market in the foreseeable future.
Expenditures for the
treatment of these diseases are on the rise and is poised to
exhibit a similar trend in the forthcoming years. As per the National
Institutes of Health (NIH), the U.S., the healthcare expenditure for autoimmune
diseases has reached half of that of the cancer expenditure.
Furthermore, the introduction of favorable policies for insurance
reimbursements are anticipated to augment the market over the next
couple of years. However, factors such as side effects, counterfeit
drugs, and expensiveness of the treatment are forecasted to check the
expansion of the autoimmune disease treatment market across the review period.
Competitive
Dashboard:
Autoimmune Disease Treatment Market Players are Abbott Laboratories, Genentech Inc., Bayer
Schering Pharma AG, Amgen Inc., Biogen Idec Inc., Chugai Pharmaceutical Co.
Ltd., Danaher, Bio-Rad, Elan Corporation Plc, F. Hoffmann-La Roche AG,
GlaxoSmithKline Plc, HYCOR Biomedical, Eli Lilly and Company, Johnson &
Johnson Inc., Siemens, Squibb Company, Merck & Co. Inc., and Thermo Fisher
Scientific.
Market Segmentation
By disease type, the
global autoimmune disease treatment market has been
segmented into localized, and systemic. The localized segment is
further sub-segmented into multiple sclerosis, inflammatory bowel disease, diabetes, and other. The
systemic segment is sub-segmented into rheumatoid arthritis, psoriasis, lupus,
and others.
By diagnosis, the
autoimmune disease treatment market has been segmented into ELISA,
dot blot, line blot, agglutination, double immune diffusion, western blotting,
multiplex immunoassay, and others.
By therapeutic products,
the market has been segmented into drugs and therapeutic
and monitoring equipment. The drugs segment is further sub-segmented into
biologics, immunosuppressant, anti-inflammatory drugs, corticosteroids, and non-steroidal
anti-inflammatory drugs.
By distribution channel,
the autoimmune disease treatment market is segmented into hospitals
& clinics, diagnostic centers, drug stores, pharmacies, and others.
Regional Analysis
The regional analysis of
the autoimmune disease treatment market spans
across Asia Pacific, Americas, Europe, and the Middle East &
Africa. Americas signifies a huge potential for growth owing to
increasing patient population. In addition, the increase witnessed in the
expenditures associated with medical facilities is prognosticated to favor
the expansion of the market over the next couple of years. The region has
been estimated to gain control over the largest share of market in the
forthcoming years.
The government of Europe
has extended firm support in favor of research & development in the
healthcare sector. This, in turn, is likely to pave the way
for the growth of the in the region. It is expected to
place the region on the second spot globally over 2023.
Asia Pacific has
unleashed immense opportunities in the market through rapid developments
witnessed in the healthcare sector. The population has also created a positive
influence on the growth of the market by increasing its healthcare
expenditures.
Heart
Transplant Market Research Report - Global Forecast till 2030
Bladder
Cancer Market Research Report - Forecast to 2030
CBD Hemp Oil
Market Research Report รข€“ Forecast to 2030
At Market Research Future (MRFR),
we enable our customers to unravel the complexity of various industries through
our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), &
Consulting Services. MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
